NCT00311649View on ClinicalTrials.gov

Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Inactivated Influenza A Vaccine A/H5N1

Trial Locations (1)

18370

Sanofi Pasteur, Swiftwater

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00311649 - Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities | Biotech Hunter | Biotech Hunter